Error: Could not add to watchlist. X

Franklin Strategic Series - Franklin Biotechnology Discovery Fund

+ Watchlist
FBDIX:US
NASDAQ GM
201.66
USD
5.34
2.72%
As of 09:29:30 ET on 06/30/2015.
Volume
0
Previous Close
196.32
52Wk Range
127.50 - 209.35
1 Yr Return
42.55%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 06/30/2015)
201.66
Total Assets (b USD) (on 05/29/2015)
2.051
Inception Date
09/15/1997
Last Dividend (on 12/15/2014)
3.7275
Dividend Indicated Gross Yield
-
Fund Managers
EVAN MCCULLOCH / JEREL BANKS
Front Load Fee
5.75%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
0.30%
Current Mgmt Fee
0.59%
Expense Ratio
1.10%
Top Fund Holdings
Name Position Value % of Fund
Celgene Corp 1.46 m 168.62 m 8.52
Biogen Inc 351.46 k 148.40 m 7.50
Gilead Sciences Inc 1.18 m 115.50 m 5.84
Amgen Inc 562.60 k 89.93 m 4.54
Puma Biotechnology Inc 278.24 k 65.70 m 3.32
Incyte Corp 711.80 k 65.24 m 3.30
BioMarin Pharmaceutical Inc 489.76 k 61.03 m 3.08
Medivation Inc 464.55 k 59.96 m 3.03
Regeneron Pharmaceuticals Inc 132.21 k 59.69 m 3.02
Illumina Inc 280.20 k 52.02 m 2.63
Profile
Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.
ADDRESS
One Franklin Parkway
Building 970, 1st Floor
San Mateo, CA 94403
PHONE
(800) 632-2350